Still did not answer why the stock price dove...lol.
And once again oversimplification....the drug has only been tested with females...NOT MALES. So no factual support for "male and females will both be using this drug on a regular basis"
Your eyes are huge...but this management team has the ability to destroy any and all value...they have thus far, despite what appears to be a huge win....yet...30-40% loss in PPS....HMMMM
If PHRMA wanted it, they would have it already. Let AMAG take the risk since the last FSDD med was a billion dollar bust. May have nothing to do with management and could be the market's invisible hand giving an invisible middle finger to "pharmaceutical grade" aphrodisiacs
I think PTN has made a very good deal with AMAG. Anayway if BREM is so good, the share price will not be at these levels for long. I still think that anybody can steal the company for peanuts with a 70% of free float.